BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired Cypex, a manufacturer of recombinant xenobiotic metabolizing enzymes, based in Dundee, Scotland. Cypex’s enzyme portfolio covers a wide range of proteins involved in drug metabolism. “We are delighted that the Cypex team is joining BioIVT, bringing with them not only their market-leading products, but also their in vitro drug metabolism technology expertise,” said Richard Haigh, ...